The impact of chronic pain patients' psychotropic drug knowledge and warning labels on the decision whether to drive a car or not

Traffic Injury Prevention

Volumn 7, Issue 4, 2006, Pages 360-364

  Veldhuijzen, D S ^a,b,c   Van Wijck, A J M ^b   Verster, J C ^a   Kalkman, C J ^b   Kenemans, J L ^a   Olivier, B ^a   Volkerts, E R ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Chronic Pain; Driving; Medicines; Psychotropic Drugs; Warning Labels

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; CAR DRIVING; CHRONIC PAIN; CONTROLLED STUDY; DRIVER LICENCE; DRIVING ABILITY; DRUG LABELING; DRUG PACKAGING; DRUG UTILIZATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PSYCHOMOTOR DISORDER; TRAFFIC SAFETY;

ACCIDENTS, TRAFFIC; ADULT; AUTOMOBILE DRIVING; CHRONIC DISEASE; DECISION MAKING; DRUG LABELING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PAIN; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; RISK FACTORS;

EID: 33751188499     PISSN: 15389588     EISSN: 1538957X     Source Type: Journal    
DOI: 10.1080/15389580600943005     Document Type: Article

References (25)

1. Agostinelli G, Grube JW. (2002) Alcohol Counter-Advertising and the Media. A Review of Recent Research. Alcohol Res. Health, Vol. 26, pp. 15-21.
2. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, MacDonald TM. (1998) Association of Road-Traffic Accidents with Benzodiazepine Use. Lancet, Vol. 352, pp. 1331-1336.
3. Beauregard LM, Barnard PW, Russo AM, Waxman HL. (1995) Perceived and Actual Risks of Driving in Patients with Arrhythmia Control Devices. Arch. Intern. Med., Vol. 155, pp. 609-613.
4. Christophersen AS, Morland J. (1997) Drugged Driving, A Review Based on the Experience in Norway. Drug Alcohol Depend., Vol. 47, pp. 125-135.
5. DeAmici D, Klersy C, Ramajoli F, Brustia L, Politi P. (2000) Impact of the Hawthorne Effect in a Longitudinal Clinical Study: The Case of Anesthesia. Control Clin. Trials, Vol. 21, pp. 103-114.
6. De Gier JJ. (2003) Medicinal Drugs: Labels and Warning, in Burns, M. Medical-Legal Aspects of Drugs. Tucson: Lawyers & Judges Publishing Company, Inc., USA
7. Gorn GJ, Lavack AM, Pollack CR, Weinberg CB. (1996) An Experiment in Designing Effective Warning Labels. Health Mark Q., Vol. 14, pp. 43-61.
8. Kelly E, Darke S, Ross J. (2004) A Review of Drug Use and Driving: Epidemiology, Impairment, Risk Factors and Risk Perceptions. Drug Alcohol Rev., Vol. 23, pp. 319-344.
9. Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH. (1994) Psychoactive Medications and Injurious Motor Vehicle Collisions Involving Older Drivers. Epidemiology, Vol. 5, pp. 591-598.
10. Lillsunde P, Korte T, Michelson L, Portman M, Pikkarainen J, Seppala T. (1996) Drugs Usage of Drivers Suspected of Driving Under the Influence of Alcohol and/or Drugs. A Study of One Week's Samples in 1979 and 1993 in Finland. Forensic Sci. Int., Vol. 77, pp. 119-129.
11. MacKinnon DP, Nohre L, Pentz MA, Stacy AW. (2000) The Alcohol Warning and Adolescents: 5-Year Effects. Am. J. Public Health, Vol. 90, pp. 1589-1594.
12. Movig KLL, Mathijssen MPM, Nagel PHA, van Egmond T, de Gier JJ, Leufkens HGH, Egberts ACG. (2004) Psychotropic Substance Use and the Risk of Motor Vehicle Accidents. Accid. Anal. Prev., Vol. 36, pp. 631-636.
13. Neutel CI. (1995) Risk of Traffic Accident Injury After a Prescription for a Benzodiazepine. Ann. Epidemiol., Vol. 5, pp. 239-244.
14. Parker RN, Saltz RF, Hennessy M. (1994) The Impact of Alcohol Beverage Container Warning Labels on Alcohol-Impaired Drivers, Drinking Drivers and the General Population in Northern California. Addiction, Vol. 89, pp. 1639-1651.
15. Peden M, Scurfield R, Sleet D, Mohan D, Hyder AA, Jarawan E, Mathers C. (2004) World Report on Road Traffic Injury Prevention, WHO, Geneva.
16. Ramaekers JG. (2003) Antidepressants and Driver Impairment: Empirical Evidence from a Standard On-The-Road Test. J. Clin. Psychiatry, Vol. 64, pp. 20-29.
17. Ray WA, Fought RL, Decker MD. (1992) Psychoactive Drugs and the Risk of Injurious Motor Vehicle Crashes in Elderly Drivers. Am. J. Epidemiol., Vol. 136, pp. 873-883.
18. Robbe HMJ, O'Hanlon JF. (1995) Acute and Subchronic Effects of Paroxetine 20 and 40 mg on Actual Driving, Psychomotor Performance and Subjective Assessments in Healthy Volunteers. Eur. Neuropsychopharmacol., Vol. 5, pp. 35-42.
19. Skurtveit S, Christophersen AS, Morland J. (1995) Female Drivers Suspected for Drunken or Drugged Driving. Forensic Sci. Int., Vol. 75, pp. 139-148.
20. Stout QF, de Gier JJ. (1982) Effect van de geel-zwarte rijvaardigheidssticker op geneesmiddelen [Effect of the Yellow-Black Warning Label for Driving on Drugs; Article in Dutch]. Pharmaceutisch Weekblad, Vol 117, pp. 449-452.
21. Veldhuijzen DS, van Wijck AJM, Verster JC, Kenemans JL, Kalkman CJ, Olivier B, Volkerts ER. (2006) Acute and Subchonic Effects of Amitriptyline 25 mg on Actual Driving in Chronic Neuropathic Pain Patients. J. Psychopharmacol. in press.
22. Verster JC, Volkerts ER. (2004) Antihistamines and Driving Ability: Evidence from On-The-Road Driving Studies During Normal Traffic. Ann. Allergy Asthma Immunol., Vol. 2, pp. 294-304.
23. Verster JC, Veldhuijzen DS, Volkerts ER. (2004) Residual Effects of Sleep Medication on Driving Ability. Sleep Med. Rev., Vol. 8, pp. 309-325.
24. Verster JC, Veldhuijzen DS, Volkerts ER. (2005) Is It Safe to Drive a Car When Treated with Anxiolytics? Evidence from On-The-Road Driving Studies During Normal Traffic. Curr. Psychiatry Rev., Vol. 1, pp. 215-225.
25. Walsh JM, de Gier JJ, Christopherson AS, Verstraete AG. (2004) Drugs and Driving. Traffic Inj. Prev., Vol. 5, pp. 241-253.